drugset / Trial / NCT04627285
A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to assess the long-term use of lacosamide oral solution dosed at 2 mg/kg/day to 12 mg/kg/day when administered to pediatric study participants with epilepsy who have completed NCT01964560 (EP0034) or NCT00938912 (SP848).
Timeline
- Start
- 2020-12-28
- Primary completion
- 2025-02-12
- Completion
- 2025-02-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacosamide | Other / unclassified | 2 mg/kg | Oral |
| Subject | Lacosamide | Other / unclassified | 12 mg/kg | Oral |